| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 660045 | 69361 | MELTEVA 0,02 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | MELTEVA 0,02 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 63 (3 x 21) comprimidos | 0,075 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69361/69361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69361/69361_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660046 | 69362 | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS, 21 comprimidos | 0,075 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69362/69362_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69362/69362_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660047 | 69362 | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS | TEVALET 0,03 mg/ 0,075 mg COMPRIMIDOS RECUBIERTOS, 63 (3 x 21) comprimidos | 0,075 mg/0,03 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69362/69362_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69362/69362_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-10-25 | 1 | 1 | 1 | 2007-10-25 | 2007-10-25 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660099 | 69387 | MIRTAZAPINA TEVAGEN 15 mg COMPRIMIDOS BUCODISPERSABLES EFG | MIRTAZAPINA TEVAGEN 15 mg COMPRIMIDOS BUCODISPERSABLES EFG , 30 comprimidos | 15 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69387/69387_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69387/69387_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-11-12 | 1 | 1 | 1 | 2007-11-12 | 2007-11-12 | 1 | 2021-02-11 | View Edit Delete | ||||||||||||
| 660101 | 69388 | MIRTAZAPINA TEVAGEN 30 mg COMPRIMIDOS BUCODISPERSABLES EFG | MIRTAZAPINA TEVAGEN 30 mg COMPRIMIDOS BUCODISPERSABLES EFG , 30 comprimidos | 30 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69388/69388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69388/69388_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-11-12 | 1 | 1 | 1 | 2007-11-12 | 2007-11-12 | 1 | 2021-02-11 | View Edit Delete | ||||||||||||
| 660154 | 69418 | ALFUZOSINA TEVA-RATIOPHARM 10 mg COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG | ALFUZOSINA TEVA-RATIOPHARM 10 mg COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69418/69418_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69418/69418_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-11-26 | 1 | 1 | 1 | 2007-11-26 | 2007-11-26 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 659827 | 69257 | LITACE 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LITACE 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69257/69257_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69257/69257_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2007-09-03 | 1 | 1 | 1 | 2007-09-03 | 2007-09-03 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 658668 | 68570 | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 20 comprimidos | 50 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68570/68570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68570/68570_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 2007-03-05 | 1 | 1 | 1 | 2007-03-05 | 2007-03-05 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 658669 | 68570 | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA | ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68570/68570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68570/68570_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 2007-03-05 | 1 | 1 | 1 | 2007-03-05 | 2007-03-05 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 659290 | 60740 | LACEROL COR RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA | LACEROL COR RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 240 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60740/60740_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60740/60740_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4840 | LACER S.A. | 1995-10-01 | 1 | 1 | 1 | 1995-10-01 | 2007-06-12 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 659672 | 62103 | VIRLIX PLUS COMPRIMIDOS DE LIBERACION PROLONGADA | VIRLIX PLUS COMPRIMIDOS DE LIBERACION PROLONGADA , 14 comprimidos | 5 mg/120 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62103/62103_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62103/62103_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4840 | LACER S.A. | 2003-05-07 | 1 | 1 | 1 | 2003-05-07 | 2003-05-07 | 1 | 2011-09-23 | View Edit Delete | ||||||||||||
| 658969 | 68755 | OLANZAPINA STADA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA STADA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68755/68755_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68755/68755_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-04 | 1 | 1 | 1 | 2007-05-04 | 2007-05-04 | 1 | 2011-05-09 | View Edit Delete | ||||||||||||
| 658970 | 68756 | OLANZAPINA STADA 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA STADA 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68756/68756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68756/68756_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-07 | 1 | 1 | 1 | 2007-05-07 | 2007-05-07 | 1 | 2011-05-09 | View Edit Delete | ||||||||||||
| 658972 | 68757 | OLANZAPINA STADA 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA STADA 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68757/68757_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68757/68757_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-07 | 1 | 1 | 1 | 2007-05-07 | 2007-05-07 | 1 | 2012-01-23 | View Edit Delete | ||||||||||||
| 658973 | 68758 | OLANZAPINA STADA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA STADA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68758/68758_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68758/68758_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-07 | 1 | 1 | 1 | 2007-05-07 | 2007-05-07 | 1 | 2022-12-21 | View Edit Delete | ||||||||||||
| 658974 | 68758 | OLANZAPINA STADA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA STADA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68758/68758_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68758/68758_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-07 | 1 | 1 | 1 | 2007-05-07 | 2007-05-07 | 1 | 2011-05-09 | View Edit Delete | ||||||||||||
| 659397 | 69008 | MIRTAZAPINA FLAS STADA 15 mg COMPRIMIDOS BUCODISPERSABLES EFG | MIRTAZAPINA FLAS STADA 15 mg COMPRIMIDOS BUCODISPERSABLES EFG, 30 comprimidos (Al/Al unidosis con pestaña) | 15 mg | 5 | 30 | 10 | 30 comprimidos (Al/Al unidosis con pestaña) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69008/69008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69008/69008_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-06-25 | 1 | 1 | 1 | 2007-06-25 | 2007-06-25 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 659398 | 69009 | MIRTAZAPINA FLAS STADA 30 mg COMPRIMIDOS BUCODISPERSABLES EFG | MIRTAZAPINA FLAS STADA 30 mg COMPRIMIDOS BUCODISPERSABLES EFG, 30 comprimidos (perforado umnidosis) | 30 mg | 5 | 30 | 10 | 30 comprimidos (perforado umnidosis) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69009/69009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69009/69009_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-06-25 | 1 | 1 | 1 | 2007-06-25 | 2007-06-25 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 659529 | 69091 | LOSARTAN / HIDROCLOROTIAZIDA STADA 50/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN / HIDROCLOROTIAZIDA STADA 50/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 50 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69091/69091_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69091/69091_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-07-10 | 1 | 1 | 1 | 2009-10-05 | 2009-10-05 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 660256 | 69477 | PARACETAMOL STADA 650 mg COMPRIMIDOS EFG | PARACETAMOL STADA 650 mg COMPRIMIDOS EFG, 20 comprimidos | 650 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69477/69477_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69477/69477_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-12-18 | 1 | 1 | 1 | 2007-12-19 | 2007-12-18 | 0 | 2011-02-17 | View Edit Delete |
Page 144 of 1035, showing 20 records out of 20697 total, starting on record 2861, ending on 2880